General

CYP-001 in adults with steroid-resistant GvHD 3:00
CYP-001 in adults with steroid-resistant GvHD
Ross Macdonald • 19 Apr 2022
Streamlining cell therapy manufacturing with CliniMACS Prodigy 2:08
Streamlining cell therapy manufacturing with CliniMACS Prodigy
Saskia Rösch • 6 Apr 2022
Implementing automation technology in the CGT space 1:28
Implementing automation technology in the CGT space
Saskia Rösch • 6 Apr 2022
Utilizing flow cytometry in CAR T-cell research 3:10
Utilizing flow cytometry in CAR T-cell research
Saskia Rösch • 6 Apr 2022
Addressing challenges in using MSCs in cell therapies 3:00
Addressing challenges in using MSCs in cell therapies
Ross Macdonald • 19 Apr 2022
Generating iSPC-derived MSCs with the Cymerus™ Platform 2:34
Generating iSPC-derived MSCs with the Cymerus™ Platform
Ross Macdonald • 19 Apr 2022
Meeting the growing demand for gene therapy manufacturing 1:36
Meeting the growing demand for gene therapy manufacturing
John Maslowski • 27 Jan 2022
Direct detection and isolation of CAR cells from patient samples 1:27
Direct detection and isolation of CAR cells from patient samples
Saskia Rösch • 6 Apr 2022
Addressing immunogenic barriers facing CRISPR-Cas9-based therapies 3:52
Addressing immunogenic barriers facing CRISPR-Cas9-based therapies
Lena Peter • 1 Apr 2022
Enhancing CAR T-cells with an AvidCAR platform 0:50
Enhancing CAR T-cells with an AvidCAR platform
Michael Traxlmayr • 1 Apr 2022
Applying AvidCAR T-cells in a clinical setting 1:09
Applying AvidCAR T-cells in a clinical setting
Michael Traxlmayr • 1 Apr 2022
Highlights in the field of Treg cells from ICLE 2022 0:42
Highlights in the field of Treg cells from ICLE 2022
Michael Traxlmayr • 1 Apr 2022
Applying CRISPR-Cas technology in advancing autologous T-cell therapies 1:50
Applying CRISPR-Cas technology in advancing autologous T-cell therapies
Mateusz Legut • 30 Mar 2022
Development and applications of OverCITE-seq 1:47
Development and applications of OverCITE-seq
Mateusz Legut • 30 Mar 2022
The use of CRISPR-Cas9 technology in the development of T cell therapies 0:55
The use of CRISPR-Cas9 technology in the development of T cell therapies
Alessio Nahmad • 31 Mar 2022
Advances in T cell metabolic profiling 2:33
Advances in T cell metabolic profiling
Daniel Gebhard • 31 Mar 2022
The content of VJRegenMed is intended for healthcare professionals